Why Appen, Bubs, InvoCare, & Volpara shares are pushing higher

Appen Ltd (ASX:APX) and Bubs Australia Ltd (ASX:BUB) shares are two of four pushing higher on Wednesday. Here's why…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

a woman

The bull market has got off to a poor start on Wednesday. In late morning trade the S&P/ASX 200 Index (ASX: XJO) is down 1.1% to 5,425.7 points.

Four shares that have not let that hold them back are listed below. Here's why they are pushing higher:

The Appen Ltd (ASX: APX) share price is up 3% to $24.90. This follows the release of a business update from the artificial intelligence company this morning. That update revealed that Appen is on target to achieve its guidance for FY 2020. This will mean full year underlying EBITDA in the range $125 million to $130 million. Which represents a 23.8% to 28.7% increase on FY 2019's underlying EBITDA of $101 million.

The Bubs Australia Ltd (ASX: BUB) share price has jumped 9% to 95 cents following the release of its third quarter update. For the quarter, the infant formula company posted record quarterly revenue of $19.7 million. This was a 67% jump on the prior corresponding period and a 36% lift on the second quarter. The company also revealed that it is now generating positive operating cashflow. Bubs recorded positive operating cashflow of $2.3 million, leaving it with a cash balance of $36.4 million.

The InvoCare Limited (ASX: IVC) share price is up 2% to $11.53. This follows the successful completion of its institutional placement. This morning the funerals company revealed that it has successfully raised $200 million from institutional investors. These funds were raised at a price of $10.40 per new share, which represents a discount of 7.8% to its last close price. InvoCare increased the size of the placement by $50 million due to strong demand.

The Volpara Health Technologies Ltd (ASX: VHT) share price has jumped 6% to $1.56 after announcing a partnership with Ambry Genetics. The cancer screening software platform provider has partnered with Ambry Genetic to bring a new era of breast care to patients in the United States. Volpara believes the collaboration agreement has the potential to significantly increase its average revenue per user upon successful clinical implementation.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended VOLPARA FPO NZ. The Motley Fool Australia owns shares of Appen Ltd. The Motley Fool Australia has recommended BUBS AUST FPO and InvoCare Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why Kingsgate, Neuren, Newcrest, and Pushpay shares are rising today

These ASX shares are avoiding the market selloff on Tuesday.

Read more »

A young woman wearing overalls and a yellow t-shirt kicks one leg in the air showing excitement over the latest ASX 200 shares to hit 52-week highs
Share Gainers

Why Neuren, Northern Star, Race Oncology, and Westgold shares are storming higher

These ASX shares are starting the week in a positive fashion.

Read more »

A woman wearing yellow smiles and drinks coffee while on laptop.
Share Gainers

Why APM, Macquarie Telecom, Northern Star, and Origin shares are rising today

These ASX shares are having a strong session despite the market selloff.

Read more »

Two boys with cardboard rockets strapped to their backs, indicating two ASX companies with rocketing share prices
Share Gainers

Catch these fast-rising 2 ASX shares before it's too late: Celeste

This pair of stocks rocketed up in February during reporting season, but are still great value for those willing to…

Read more »

three businessmen high five each other outside an office building with graphic images of graphs and metrics superimposed on the shot.
Share Gainers

Why Arafura, Myer, Volpara, and Xero shares are zooming higher

These ASX shares are making their shareholders smile on Thursday.

Read more »

medical asx share price represented by doctor giving thumbs up
Healthcare Shares

Guess which ASX biotech stock just rocketed 29% on big FDA news

The ASX healthcare share is attracting investor interest following FDA approval for its targeted cancer therapy compound.

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Share Gainers

Why Mesoblast, PolyNovo, Pushpay, and Weebit Nano shares are charging higher

These ASX shares are having a strong session despite the market selloff.

Read more »

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why InvoCare, Pentanet, Sayona Mining, and Weebit Nano shares are storming higher

These ASX shares are having a strong session on Tuesday.

Read more »